Hikma Pharmaceuticals USA 00641617701 - Oc… | USA MedPremium
Octreotide Acetate 200 mcg/mL Injection for Acromegaly & Diarrhea Control
USAMP#72939353SKU: 00641617701Hikma Pharmaceuticals USA
License Required
Product Spotlight
High-quality Octreotide Acetate 200 mcg/mL Injection, designed for effective management of symptoms associated with acromegaly, carcinoid tumors, and severe diarrhea and flushing episodes in patients with metastatic carcinoid tumors and vasoactive intestinal peptide-secreting tumors (VIPomas).
Manufactured by Hikma Pharmaceuticals USA, ensuring pharmaceutical-grade quality and consistency in every 5 mL multiple-dose vial.
Easy-to-use injection form, providing precise dosage control for healthcare professionals.
Requires refrigeration to maintain its efficacy and stability, guaranteeing optimal performance up to its expiration date.
Latex-free packaging to minimize allergic reactions and ensure safety for patients with latex sensitivities.
